Moran Wealth Management’s Bioventus BVS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q1
– Sell
-23,928
Closed -$251K – 445
2024
Q4
$251K Hold
23,928
– – 0.01% 391
2024
Q3
$286K Hold
23,928
– – 0.01% 391
2024
Q2
$138K Hold
23,928
– – ﹤0.01% 387
2024
Q1
$124K Sell
23,928
-349
-1% -$1.71K ﹤0.01% 408
2023
Q4
$128K Sell
24,277
-2,349
-9% -$9.29K ﹤0.01% 411
2023
Q3
$87.9K Buy
26,626
+784
+3% +$2.75K ﹤0.01% 364
2023
Q2
$74.7K Hold
25,842
– – ﹤0.01% 379
2023
Q1
$27.7K Buy
+25,842
New +$49.4K ﹤0.01% 355

Other funds holding BVS

Moran Wealth Management's BVS Position: Q1 2025 in Review

Moran Wealth Management sold out of Bioventus (BVS) in Q1 2025, closing a stake of 23,928 shares — an estimated $251K sold.

Moran Wealth Management first reported a position in BVS in Q1 2023 and held it in 8 quarters. The position peaked at $286K in Q3 2024. 144 funds tracked by Wall St. Rank hold BVS as of Q1 2025.

  • Moran Wealth Management reported no remaining Bioventus position as of Q1 2025 after selling out during the quarter.
  • Moran Wealth Management sold 23,928 Bioventus shares in Q1 2025, an estimated $251K.
  • Moran Wealth Management first reported a position in Bioventus in Q1 2023 and held it in 8 quarters.
  • Moran Wealth Management's Bioventus position peaked at $286K in Q3 2024.
  • 144 funds tracked by Wall St. Rank held Bioventus as of Q1 2025.

Based on Moran Wealth Management's 13F filing for Q1 2025, filed 23 Apr 2025.